Safety of bevacizumab versus no-bevacizumab treatment used on metastatic colorectal cancer: a systematic review and metanalysis

被引：0
|
作者：
Silva, W. C. [1 ]
Lima, E. M. E. A. [2 ]
Araujo, V. E. [1 ]
Santos, J. B. R. [1 ]
Silva, M. R. R. [1 ]
Cherchiglia, M. L. [1 ]
Andrade, E. I. G. [1 ]
机构：
[1] Univ Fed Minas Gerais, Postgrad Programme Med & Pharmaceut Assistance, Coll Pharm, Belo Horizonte, MG, Brazil
[2] Mario Penna Inst, Oncol, Belo Horizonte, MG, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
10.1016/S0959-8049(17)30258-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
447
引用
收藏
页码：S54 / S55
页数：5
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab and panitumumab) in the treatment of metastatic colorectal cancer: Systematic review and metanalysis.
    Silva, Wania Cristina
    Lima, Ellias Magalhaes Abreu
    Araujo, Vania Eloisa
    Santos, Jessica Barreto Ribeiro
    Silva, Michael Ruberson Ribeiro
    Acurcio, Francisco Assis
    Cherchiglia, Mariangela Leal
    Andrade, Eli Iola Gurgel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis
    Kaveh, Sara
    Ebrahimi, Parvin
    Rezapour, Aziz
    Mozafari, Masoud
    Sayehmiri, Kourosh
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 30 - 41
  • [3] Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis
    Sara Kaveh
    Parvin Ebrahimi
    Aziz Rezapour
    Masoud Mozafari
    Kourosh Sayehmiri
    International Journal of Clinical Pharmacy, 2019, 41 : 30 - 41
  • [4] Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
    Tappenden, P.
    Jones, R.
    Paisley, S.
    Carroll, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (12) : 1 - +
  • [5] SAFETY OF BEVACIZUMAB USED IN ROUTINE PRACTICE IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Dzienis, M.
    Malczewski, A.
    Goh, J.
    Hughes, B.
    Eastgate, M.
    Wyld, D.
    Burge, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 50 - 50
  • [6] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
    Cui, Yuying
    Guo, Yingxue
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) : 843 - 851
  • [7] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
    Yuying Cui
    Yingxue Guo
    International Journal of Clinical Pharmacy, 2022, 44 : 843 - 851
  • [8] Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis
    Yuying Cui
    Yingxue Guo
    International Journal of Clinical Pharmacy, 2024, 46 : 555 - 557
  • [9] SAFETY PROFILE OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Castillo, M. A.
    Ubago, R.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A437 - A437
  • [10] Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis
    Song, Yu
    Mao, Qianqian
    Zhou, Manling
    Liu, Cheng-Jiang
    Kong, Li
    Hu, Ting
    BMC GASTROENTEROLOGY, 2024, 24 (01)
12345